Avidity Partners Management’s Medtronic MDT Stock Holding History

Avidity Partners Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.48M	Sell	70,000 -130,000	-65%	-$10.5M	0.88%	17
2026 Q1	$16.8M	Buy	200,000 +92,400	+86%	+$8.85M	1.79%	12
2025 Q4	$10.3M	Sell	107,600 -83,000	-44%	-$8.06M	2.98%	7
2025 Q3	$18.2M	Buy	+190,600	New	+$17.5M	4.13%	3
2021 Q3	–	Sell	-535,000	Closed	-$66.4M	–	120
2021 Q2	$66.4M	Sell	535,000 -489,200	-48%	-$61.4M	1.79%	15
2021 Q1	$121M	Buy	1,024,200 +723,200	+240%	+$84.8M	3.34%	4
2020 Q4	$35.3M	Buy	301,000 +120,000	+66%	+$13.2M	1.14%	31
2020 Q3	$18.8M	Buy	181,000 +7,300	+4%	+$733K	0.87%	36
2020 Q2	$15.9M	Buy	+173,700	New	+$16.7M	1.02%	39

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Avidity Partners Management's MDT Position: Q2 2026 in Review

Avidity Partners Management reduced its Medtronic (MDT) stake by 65% in Q2 2026, selling an estimated $10.5M and leaving 70,000 shares worth $5.48M. The position accounts for 0.88% of the portfolio, ranked #17.

Avidity Partners Management first reported a position in MDT in Q2 2020 and has held it in 9 quarters since. The position peaked at $121M in Q1 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Avidity Partners Management held 70,000 shares of Medtronic worth $5.48M as of Q2 2026.
Avidity Partners Management sold 130,000 Medtronic shares in Q2 2026, an estimated $10.5M.
Medtronic made up 0.88% of Avidity Partners Management's portfolio in Q2 2026, its #17 holding.
Avidity Partners Management first reported a position in Medtronic in Q2 2020 and has held it in 9 quarters since.
Avidity Partners Management's Medtronic position peaked at $121M in Q1 2021.
2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Avidity Partners Management's 13F filing for Q2 2026, filed 14 Aug 2026.